WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlexander Rialdi, Arvin C. Dar, Manikandan Lakshmanan et al.|Nature Cancer|2023Cited by 27
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Molecular Cancer Therapeutics|2019Cited by 21
Supplementary Synthetic Methods from Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Unknown|2023Cited by 0
Supplementary Data Figures 1-7 from Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Unknown|2023Cited by 0
Supplementary Data Tables 1-3 from Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Unknown|2023Cited by 0